Results

ArticleS7710

On the Role of Belief in Science

Avi Loeb. avi-loeb.medium.com. October 7, 2026.

Loeb compares religious commitment with physicists’ continued belief in supersymmetry after reported null collider results. He distinguishes scientific disputes from metaphysical questions and hypothesizes that advanced alien technology might appear divine. These are an attributed scientific/philosophical argument and a conditional scenario, not a reported encounter. His biography’s advisory roles are self-description, and the gifted artwork is not an insider approach. Underlying results and historical accounts were not checked in this reading.

Complete supplied author essay; underlying science and images unreviewed
ArticleS7467

New Study: Missing Data Behind 112 UAP Videos

Richard Dolan. richarddolanmembers.com. August 19, 2026.

Dolan discusses research on missing information in released UAP videos and its consequences for interpreting motion.

Public article text read
ArticleS7504

Social-Media UAP Influencers Misunderstand How Science Works!

Avi Loeb. avi-loeb.medium.com. July 8, 2026.

Loeb says he invited John Birks to a council Zoom discussion about a dust-cloud hypothesis. Birks’ concessions and Hanson/Claude criticisms are relayed without original correspondence. Loeb expressly says public UAP data remains unresolved.

Supplied author text read
ArticleS7741

Resolving the Nature of Unidentified Anomalous Phenomena (UAP) by Scientific Evidence

Avi Loeb. avi-loeb.medium.com. June 2026.

Loeb describes a first council meeting and repeats his account of government tasking. He states an unclassified-information limit and outlines prospective scientific review; original appointment and meeting records were not supplied.

Complete supplied author essay; tasking and meeting records missing
PaperS7697

Reprogramming of stroma-derived chemokine networks drives the loss of tissue organization in nodal B cell lymphoma

Felix Czernilofsky, Anna Mathioudaki, Lea Jopp-Saile, Raphael Lutz, Dominik Vonficht, Xi Wang, Christina Schniederjohann, Harald Voehringer, Tobias Roider, Marc-Andrea Baertsch, Claus Rodemer, Henry Löffler-Wirth, Michael Grau, Donnacha Fitzgerald, Johannes Mammen, Jan Kosla, Nora Liebers, Peter-Martin Bruch, Diana Ordoñez-Rueda, Alexander Brobeil, Gunhild Mechtersheimer, Caroline Pabst, Carsten Müller-Tidow, Andreas Trumpp, Marc Seifert, Frank Neumann, Mathias Heikenwälder, Vladimir Benes, Wolfgang Huber, Jörg Distler, Georg Lenz, Hans Binder, Reiner Siebert, Garry P. Nolan, Moritz Gerstung, Judith B. Zaugg, Daniel Hübschmann, Simon Haas, Sascha Dietrich. pmc.ncbi.nlm.nih.gov. March 25, 2026.

This lymphoma study combines new tissue profiling, reused datasets, limited cell cultures and retrospective survival associations to propose a model of altered tissue organization. Its assays overlap an earlier Nolan-linked atlas, and cells or repeated measurements are not independent patients. Data-derived survival thresholds and unresolved denominator/method wording qualify clinical interpretation. Nolan provided access to existing imaging and immune datasets; this article does not assign him a funding award or report a classified UAP approach.

Complete specialist supplied XML text; native apparatus unreviewed
PaperS7508

Estimating time since influenza virus exposure using single-cell proteomic data

Klodiana Rizzo Nervo, Neda Hajiakhoond Bidoki, Han Chen, Zainab Rahil, Zach Bjornson, Kenneth Kim, Bonnie Bock, Melton Affrime, Logan Bauerle, Pham Bao Tran Huynh, David Liebowitz, Sean Tucker, Pier Federico Gherardini, Garry P. Nolan, Nima Aghaeepour, David R. McIlwain. frontiersin.org. March 19, 2026.

Rizzo Nervo, Nolan and colleagues model influenza shedding and time since exposure in two controlled challenge datasets. Preinfection baselines and selected healthy cohorts constrain generalization. Several count, legend, validation-method and error-metric descriptions disagree; this is not a UAP-exposure study.

Article, figures and narrative supplements read
PaperS7678

Annotation-free discovery of disease-relevant cells in single-cell datasets

Erin Craig, Timothy J Keyes, Jolanda Sarno, Jeremy P D’Silva, Pablo Domizi, Maxim Zaslavsky, Albert Tsai, David Glass, Garry P Nolan, Trevor Hastie, Robert Tibshirani, Kara L Davis. ebi.ac.uk. August 27, 2025.

This Nolan-coauthored computational study estimates disease-associated cells using patient disease labels and a healthy baseline, without requiring expert cell annotations. Reported leukemia examples support a research method, with stronger expert-label benchmarks, small patient cohorts and assumptions that limit interpretation. Millions of measured cells do not imply millions of independent patients. Disclosed NIH support does not establish a classified programme or UAP access.

Complete supplied XML text; graphics, algorithms and supplements unreviewed
PaperS7758

Comment on "Discovery and Preliminary Characterization of a Third Interstellar Object: 3I/ATLAS" [arXiv:2507.02757]

Abraham Loeb. arxiv.org. July 9, 2025.

Loeb models a population mass budget for 3I/ATLAS and offers ordinary cometary-core or rarer-population alternatives. Technological design is conditional speculation; albedo, size, selection and reservoir assumptions remain explicit, with no artificial-origin detection or independent model validation.

Complete supplied three-page v2 manuscript; model and date gaps retained
PaperS7695

Quantitative characterization of tissue states using multiomics and ecological spatial analysis

Daisy Yi Ding, Zeyu Tang, Bokai Zhu, Hongyu Ren, Alex K. Shalek, Robert Tibshirani, Garry P. Nolan. pmc.ncbi.nlm.nih.gov. April 1, 2025.

This computational study reanalyses existing tissue datasets to describe spatial cell diversity and infer molecular relationships. Its liver comparison has one tissue per condition, subdivided into ten regions; these are not ten patients. Colorectal-cancer survival models use internal validation. Nolan is explicitly acknowledged for NIH support and two FDA Medical Countermeasures Initiative contracts. Those public acknowledgements establish reported research support, without verifying contract scope or a classified UAP approach.

Complete specialist supplied XML text; native apparatus unreviewed
PaperS7706

High-throughput multiplexed serology via the mass-spectrometric analysis of isotopically barcoded beads

Alexandros P Drainas, David R McIlwain, Alec Dallas, Theresa Chu, Antonio Delgado-González, Maya Baron, Maria Angulo-Ibáñez, Angelica Trejo, Yunhao Bai, John W Hickey, Guolan Lu, Scott Lu, Jesus Pineda-Ramirez, Khamal Anglin, Eugene T Richardson, John C Prostko, Edwin Frias, Venice Servellita, Noah Brazer, Charles Y Chiu, Michael J Peluso, Jeffrey N Martin, Oliver F Wirz, Tho D Pham, Scott D Boyd, J Daniel Kelly, Julien Sage, Garry P Nolan, Xavier Rovira-Clavé. pmc.ncbi.nlm.nih.gov. February 12, 2025.

This serology technology article was reviewed only for descriptive background, author roles, funding, disclosures and bibliography. Aggregate assay counts do not establish independent participant counts or clinical performance; their target-count arithmetic remains unresolved within this scope. Nolan shares an acknowledged NIH award with Julien Sage and is a corresponding author/joint supervisor. Patent and company interests are declared. Results, Discussion, Methods and figure captions remain excluded; no UAP or private-approach inference follows.

Partial descriptive XML; Results, Discussion and Methods excluded
PaperS7701

A multi-omics spatial framework for host-microbiome dissection within the intestinal tissue microenvironment

Bokai Zhu, Yunhao Bai, Yao Yu Yeo, Xiaowei Lu, Xavier Rovira-Clavé, Han Chen, Jason Yeung, Dingani Nkosi, Jonathan Glickman, Antonio Delgado-Gonzalez, Georg K. Gerber, Mike Angelo, Alex K. Shalek, Garry P. Nolan, Sizun Jiang. pmc.ncbi.nlm.nih.gov. January 31, 2025.

This mouse-intestine study combines spatial imaging, gene-expression and glycan measurements to examine inflammation-associated patterns. Its many cells and regions come from eight main-cohort mice, and correlations do not establish microbial causation or clinical performance. Nolan is a corresponding author and joint supervisor. The reviewed scope is partial, with biological-validation sections and Methods excluded; public support and commercial disclosures do not establish a UAP programme or private approach.

Partial specialist XML; validation and Methods excluded

A curated public selection. Source review describes what was read; it does not establish that a claim is true. Our research approach